Related references
Note: Only part of the references are listed.Tyrosinemia Type 1 and symptoms of ADHD: Biochemical mechanisms and implications for treatment and prognosis
Helene Barone et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2020)
Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria
Alex Pinto et al.
NUTRIENTS (2019)
Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
Willem G. van Ginkel et al.
NUTRIENTS (2019)
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations
Jeffrey M. Chinsky et al.
GENETICS IN MEDICINE (2017)
Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
Maria Ignacia Garcia et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2017)
Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice
Megan A. Hillgartner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Outcome of children with hereditary tyrosinaemia following newborn screening
P. J. McKiernan et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone
Fatiha Bendadi et al.
JOURNAL OF PEDIATRICS (2014)
Single amino acid supplementation in aminoacidopathies: a systematic review
Danique van Vliet et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice
Sebene Mayorandan et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Recommendations for the management of tyrosinaemia type 1
Corinne de Laet et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?
A. Daly et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2012)
Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Quebec
Jean Larochelle et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Tyrosinemia type 1 in Spain: Mutational analysis, treatment and long-term outcome
Maria Luz Couce et al.
PEDIATRICS INTERNATIONAL (2011)
Dietary management practices in phenylketonuria across European centres
Kirsten Ahring et al.
CLINICAL NUTRITION (2009)
Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes
Erin L. MacLeod et al.
MOLECULAR GENETICS AND METABOLISM (2009)
NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients
A. Masurel-Paulet et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Behavioural factors related to metabolic control in patients with phenylketonuria
MR Crone et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
How practical are recommendations for dietary control in phenylketonuria?
JH Walter et al.
LANCET (2002)
Outcome of tyrosinaemia type III
CJ Ellaway et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia
CJ Wilson et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2000)
Share Paper
